J.D. Fitzgerald

1.3k total citations · 1 hit paper
15 papers, 1.0k citations indexed

About

J.D. Fitzgerald is a scholar working on Molecular Biology, Animal Science and Zoology and Biochemistry. According to data from OpenAlex, J.D. Fitzgerald has authored 15 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Animal Science and Zoology and 3 papers in Biochemistry. Recurrent topics in J.D. Fitzgerald's work include Receptor Mechanisms and Signaling (5 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Analytical Methods in Pharmaceuticals (3 papers). J.D. Fitzgerald is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Analytical Methods in Pharmaceuticals (3 papers). J.D. Fitzgerald collaborates with scholars based in United Kingdom, Canada and Australia. J.D. Fitzgerald's co-authors include Janet Wale, Andrew J. Bilski, Stella R. O’Donnell, J McAinsh, A. S. Rebuck, Richard E. Ruffin, R. Ruffin, Jackson Hamilton, Eugene S. Handler and Francis C. Monette and has published in prestigious journals such as The Lancet, Journal of Allergy and Clinical Immunology and British Journal of Pharmacology.

In The Last Decade

J.D. Fitzgerald

14 papers receiving 901 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Pharmacology of a β2-Selective Adrenoceptor Antagonist (ICI 118,551)

1983 387 citations Andrew J. Bilski, J.D. Fitzgerald et al. Journal of Cardiovascular Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.D. Fitzgerald United Kingdom	9	347	249	248	198	157	15	1.0k
R T Brittain United Kingdom	20	474 1.4×	135 0.5×	412 1.7×	333 1.7×	277 1.8×	46	1.4k
W. Schaumann Germany	15	318 0.9×	208 0.8×	228 0.9×	297 1.5×	36 0.2×	90	1.1k
J. F. Giudicelli France	20	404 1.2×	547 2.2×	268 1.1×	216 1.1×	63 0.4×	55	1.2k
Mark Nickerson Canada	24	707 2.0×	308 1.2×	446 1.8×	449 2.3×	193 1.2×	74	1.7k
Marianne Frisk‐Holmberg Sweden	21	215 0.6×	300 1.2×	141 0.6×	78 0.4×	69 0.4×	54	1.3k
Bengt Åblad Sweden	21	498 1.4×	746 3.0×	330 1.3×	274 1.4×	227 1.4×	52	1.7k
J E Waddell United States	15	621 1.8×	163 0.7×	268 1.1×	401 2.0×	136 0.9×	17	1.1k
Graham P. Jackman Australia	20	271 0.8×	603 2.4×	221 0.9×	173 0.9×	97 0.6×	53	1.3k
T Zsoter Canada	17	254 0.7×	314 1.3×	191 0.8×	122 0.6×	40 0.3×	58	918
Mme Hélène Schmitt France	10	385 1.1×	215 0.9×	234 0.9×	371 1.9×	58 0.4×	10	951

Countries citing papers authored by J.D. Fitzgerald

Since Specialization

Citations

This map shows the geographic impact of J.D. Fitzgerald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.D. Fitzgerald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.D. Fitzgerald more than expected).

Fields of papers citing papers by J.D. Fitzgerald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.D. Fitzgerald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.D. Fitzgerald. The network helps show where J.D. Fitzgerald may publish in the future.

Co-authorship network of co-authors of J.D. Fitzgerald

This figure shows the co-authorship network connecting the top 25 collaborators of J.D. Fitzgerald. A scholar is included among the top collaborators of J.D. Fitzgerald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.D. Fitzgerald. J.D. Fitzgerald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Fitzgerald, J.D.. (2002). The evaluation of bromsulphalein following cholecystographic studies.. PubMed. 23(3). 165–6.

2.

Bilski, Andrew J., et al.. (1983). The Pharmacology of a β2-Selective Adrenoceptor Antagonist (ICI 118,551). Journal of Cardiovascular Pharmacology. 5(3). 430–437. 387 indexed citations breakdown →

3.

Fitzgerald, J.D., et al.. (1978). Studies on the pharmacokinetics and pharmacodynamics of atenolol in man. European Journal of Clinical Pharmacology. 13(2). 81–89. 107 indexed citations

4.

Fitzgerald, J.D. & Stella R. O’Donnell. (1978). THE ANTAGONISM BY PROPRANOLOL AND α‐METHYLPROPRANOLOL (ICI 77602) OF VASCULAR AND CARDIAC RESPONSES TO ISOPRENALINE IN ANAESTHETIZED DOGS. Clinical and Experimental Pharmacology and Physiology. 5(6). 579–586. 7 indexed citations

5.

Ruffin, Richard E., J.D. Fitzgerald, & A. S. Rebuck. (1977). A comparison of the bronchodilator activity of Sch 1000 and salbutamol. Journal of Allergy and Clinical Immunology. 59(2). 136–141. 78 indexed citations

6.

Fitzgerald, J.D., et al.. (1976). Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta‐adrenoceptor blocking drug.. British Journal of Clinical Pharmacology. 3(2). 267–272. 83 indexed citations

7.

Fitzgerald, J.D.. (1972). Selective Beta-Adrenergic Receptor Active Drugs [Abridged]. Proceedings of the Royal Society of Medicine. 65(9). 761–764. 5 indexed citations

8.

Fitzgerald, J.D. & Stella R. O’Donnell. (1971). Pharmacology of 4‐hydroxypropranolol, a metabolite of propranolol. British Journal of Pharmacology. 43(1). 222–235. 105 indexed citations

9.

Fitzgerald, J.D.. (1971). Experimental approaches to the prophylaxis and treatment of ischaemic heart disease. Postgraduate Medical Journal. 47(543). 36–43. 2 indexed citations

10.

Fitzgerald, J.D.. (1969). Perspectives in adrenergic beta‐receptor blockade. Clinical Pharmacology & Therapeutics. 10(3). 292–306. 173 indexed citations

11.

Fitzgerald, J.D.. (1967). Propranolol-induced depression.. BMJ. 2(5548). 372.2–373. 25 indexed citations

12.

Fitzgerald, J.D. & A. M. Barrett. (1967). WHAT IS A β-BLOCKER?. The Lancet. 290(7514). 509–509. 4 indexed citations

13.

Steinberg, Bernhard, Joseph LoBue, Eugene S. Handler, et al.. (1965). A Series of Monographs. Acta Haematologica. 33(5). 320–320. 37 indexed citations

14.

Rhodes, J., E. H. Reynolds, J.D. Fitzgerald, & Paul Fourman. (1963). EXAGGERATED RESPONSE TO PARATHYROID EXTRACT IN SARCOIDOSIS. The Lancet. 282(7308). 598–601. 5 indexed citations

15.

Fitzgerald, J.D., et al.. (1951). Diffuse glomerulonephritis induced in rabbits by small intravenous injections of horse serum.. PubMed. 51(1). 1–11. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact